ArticleFrontiers in oncology2022

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.

Ke Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.